MICROTITRATION OF RUBELLA VIRUS IN MONOVALENT VACCINAL PRODUCTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ESNA ASHARI F.; SHAFYI A.; TAQAVIAN M.; MOHAMMADI A.; SADIGH Z.A.; SABIRI GH.H.; MIRSHAHREZA H.; HAMZEHLOO Z.; TALEBLUE F.; SHEIKH MOHAMMADI N.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Public Health Year:2011 | Volume:40 | Issue:1 Page(s): 68-71

Download Full-Text

View:

359

Download:

112

Cites:

Information Journal Paper

Title

MICROTITRATION OF RUBELLA VIRUS IN MONOVALENT VACCINAL PRODUCTS

Author(s)

Keywords

MICROTITRATION

RUBELLA VIRUS

POTENCY TEST

MICROPLATE

Abstract

Background: POTENCY TEST for control of rubella vaccine is a significant factor to qualify production line and vaccination program. For this reason, WHO recommends to use the MICROTITRATION method by both vaccine companies and control laboratories. Then the study was done to improve this test.Methods: Three RUBELLA VIRUS samples, including an in-house standard, a lot of vaccine and an in- process product, were tittered in cell culture tubes. Then micro titration steps were tested on 96-well MICROPLATE using cocultivation of standard rubella vaccine dilutions and RK- 13 cell line. After 6-7 days, final reading was done and calculated the titer. Two other samples were assayed with the micromethod.Results: Titer reduction less than 0.5 log was acquired for each sample during frequent tests and between two methods.Conclusion: The procedure was profitable and accurate for potency and identity tests of RUBELLA VIRUS vaccine, on the basis of WHO recommendations

Cites

No record.

References

No record.

Cite

APA: Copy

ESNA ASHARI, F., SHAFYI, A., TAQAVIAN, M., MOHAMMADI, A., SADIGH, Z.A., SABIRI, GH.H., MIRSHAHREZA, H., HAMZEHLOO, Z., TALEBLUE, F., & SHEIKH MOHAMMADI, N.. (2011). MICROTITRATION OF RUBELLA VIRUS IN MONOVALENT VACCINAL PRODUCTS. IRANIAN JOURNAL OF PUBLIC HEALTH, 40(1), 68-71. SID. https://sid.ir/paper/272774/en

Vancouver: Copy

ESNA ASHARI F., SHAFYI A., TAQAVIAN M., MOHAMMADI A., SADIGH Z.A., SABIRI GH.H., MIRSHAHREZA H., HAMZEHLOO Z., TALEBLUE F., SHEIKH MOHAMMADI N.. MICROTITRATION OF RUBELLA VIRUS IN MONOVALENT VACCINAL PRODUCTS. IRANIAN JOURNAL OF PUBLIC HEALTH[Internet]. 2011;40(1):68-71. Available from: https://sid.ir/paper/272774/en

IEEE: Copy

F. ESNA ASHARI, A. SHAFYI, M. TAQAVIAN, A. MOHAMMADI, Z.A. SADIGH, GH.H. SABIRI, H. MIRSHAHREZA, Z. HAMZEHLOO, F. TALEBLUE, and N. SHEIKH MOHAMMADI, “MICROTITRATION OF RUBELLA VIRUS IN MONOVALENT VACCINAL PRODUCTS,” IRANIAN JOURNAL OF PUBLIC HEALTH, vol. 40, no. 1, pp. 68–71, 2011, [Online]. Available: https://sid.ir/paper/272774/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops